Published in Arthritis Rheum on March 01, 2009
Anatomically shaped tissue-engineered cartilage with tunable and inducible anticytokine delivery for biological joint resurfacing. Proc Natl Acad Sci U S A (2016) 1.51
CRISPR/Cas9 editing of induced pluripotent stem cells for engineering inflammation-resistant tissues. Arthritis Rheumatol (2016) 1.39
Effect of Short-Term Stimulation with Interleukin-1β and Differentiation Medium on Human Mesenchymal Stromal Cell Paracrine Activity in Coculture with Osteoblasts. Biomed Res Int (2015) 1.38
The NFκB pathway: a therapeutic target in glioblastoma. Oncotarget (2011) 1.25
Functions of nuclear factor kappaB in bone. Ann N Y Acad Sci (2010) 1.21
The role of changes in extracellular matrix of cartilage in the presence of inflammation on the pathology of osteoarthritis. Biomed Res Int (2013) 1.18
Inflammatory cytokines induce a unique mineralizing phenotype in mesenchymal stem cells derived from human bone marrow. J Biol Chem (2013) 1.04
Nuclear factor-κB modulates osteogenesis of periodontal ligament stem cells through competition with β-catenin signaling in inflammatory microenvironments. Cell Death Dis (2013) 1.02
Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis. Arthritis Res Ther (2009) 1.01
Biochemical and proteomic characterization of alkaptonuric chondrocytes. J Cell Physiol (2012) 0.99
Reamer-irrigator-aspirator indications and clinical results: a systematic review. Int Orthop (2011) 0.97
Tumor necrosis factor alpha inhibits olfactory regeneration in a transgenic model of chronic rhinosinusitis-associated olfactory loss. Am J Rhinol Allergy (2011) 0.97
Activation of NF-κB/p65 facilitates early chondrogenic differentiation during endochondral ossification. PLoS One (2012) 0.93
Interleukin-1 beta and tumor necrosis factor alpha inhibit migration activity of chondrogenic progenitor cells from non-fibrillated osteoarthritic cartilage. Arthritis Res Ther (2013) 0.93
Inflammation as death or life signal in diabetic fracture healing. Inflamm Res (2010) 0.93
Cell encapsulating biomaterial regulates mesenchymal stromal/stem cell differentiation and macrophage immunophenotype. Stem Cells Transl Med (2012) 0.92
The inhibition by interleukin 1 of MSC chondrogenesis and the development of biomechanical properties in biomimetic 3D woven PCL scaffolds. Biomaterials (2012) 0.92
Intersection of inflammation and herbal medicine in the treatment of osteoarthritis. Curr Rheumatol Rep (2012) 0.90
Advances in regenerative orthopedics. Mayo Clin Proc (2013) 0.89
IL-17 inhibits chondrogenic differentiation of human mesenchymal stem cells. PLoS One (2013) 0.89
Engineered cartilage maturation regulates cytokine production and interleukin-1β response. Clin Orthop Relat Res (2011) 0.89
Antioxidation of decellularized stem cell matrix promotes human synovium-derived stem cell-based chondrogenesis. Stem Cells Dev (2012) 0.88
Osteoarthritis prevention through meniscal regeneration induced by intra-articular injection of meniscus stem cells. Stem Cells Dev (2013) 0.88
ER stress, p66shc, and p-Akt/Akt mediate adjuvant-induced inflammation, which is blunted by argirein, a supermolecule and rhein in rats. Inflammation (2012) 0.87
Tissue-engineered cartilage with inducible and tunable immunomodulatory properties. Biomaterials (2014) 0.86
Gene therapy approaches to regenerating the musculoskeletal system. Nat Rev Rheumatol (2015) 0.84
Immune modulation to improve tissue engineering outcomes for cartilage repair in the osteoarthritic joint. Tissue Eng Part B Rev (2014) 0.81
Human genome-wide expression analysis reorients the study of inflammatory mediators and biomechanics in osteoarthritis. Osteoarthritis Cartilage (2015) 0.81
Comparison of drug and cell-based delivery: engineered adult mesenchymal stem cells expressing soluble tumor necrosis factor receptor II prevent arthritis in mouse and rat animal models. Stem Cells Transl Med (2013) 0.81
Effects of the pro-inflammatory milieu on the dedifferentiation of cultured fibroblast-like synoviocytes. Mol Med Rep (2012) 0.81
A high-throughput model of post-traumatic osteoarthritis using engineered cartilage tissue analogs. Osteoarthritis Cartilage (2014) 0.81
Effect of interleukin-1β treatment on co-cultures of human meniscus cells and bone marrow mesenchymal stromal cells. BMC Musculoskelet Disord (2013) 0.80
Acquiring chondrocyte phenotype from human mesenchymal stem cells under inflammatory conditions. Int J Mol Sci (2014) 0.80
CD146(+) mesenchymal stem cells display greater therapeutic potential than CD146(-) cells for treating collagen-induced arthritis in mice. Stem Cell Res Ther (2016) 0.79
Resveratrol has anabolic effects on disc degeneration in a rabbit model. J Korean Med Sci (2013) 0.79
Role of Chondrocytes in Cartilage Formation, Progression of Osteoarthritis and Cartilage Regeneration. J Dev Biol (2015) 0.78
RB1CC1 protein suppresses type II collagen synthesis in chondrocytes and causes dwarfism. J Biol Chem (2011) 0.78
The influence of IL-10 and TNFα on chondrogenesis of human mesenchymal stromal cells in three-dimensional cultures. Int J Mol Sci (2014) 0.78
Characterizing heterogeneity in the response of synovial mesenchymal progenitor cells to synovial macrophages in normal individuals and patients with osteoarthritis. J Inflamm (Lond) (2016) 0.77
TNFα and IL-1β influence the differentiation and migration of murine MSCs independently of the NF-κB pathway. Stem Cell Res Ther (2014) 0.77
Personalizing Stem Cell Research and Therapy: The Arduous Road Ahead or Missed Opportunity? Curr Pharmacogenomics Person Med (2010) 0.77
Effects of CD14 macrophages and proinflammatory cytokines on chondrogenesis in osteoarthritic synovium-derived stem cells. Tissue Eng Part A (2014) 0.77
Promyelocytic leukemia zinc-finger induction signs mesenchymal stem cell commitment: identification of a key marker for stemness maintenance? Stem Cell Res Ther (2014) 0.77
Tormentic Acid Inhibits IL-1β-Induced Inflammatory Response in Human Osteoarthritic Chondrocytes. Inflammation (2016) 0.77
Reverse Dynamization: Influence of Fixator Stiffness on the Mode and Efficiency of Large-Bone-Defect Healing at Different Doses of rhBMP-2. J Bone Joint Surg Am (2016) 0.76
Muscle cell-derived factors inhibit inflammatory stimuli-induced damage in hMSC-derived chondrocytes. Osteoarthritis Cartilage (2013) 0.76
Articular cartilage tissue engineering: the role of signaling molecules. Cell Mol Life Sci (2016) 0.75
Regenerative medicine in 2016: Important milestones on the way to clinical translation. Nat Rev Rheumatol (2017) 0.75
Electrospun Microfiber Scaffolds with Anti-Inflammatory Tributanoylated N-Acetyl-d-Glucosamine Promote Cartilage Regeneration. Tissue Eng Part A (2016) 0.75
CD200 expression in human cultured bone marrow mesenchymal stem cells is induced by pro-osteogenic and pro-inflammatory cues. J Cell Mol Med (2016) 0.75
Yields and chondrogenic potential of primary synovial mesenchymal stem cells are comparable between rheumatoid arthritis and osteoarthritis patients. Stem Cell Res Ther (2017) 0.75
Stem cells in degenerative orthopaedic pathologies: effects of aging on therapeutic potential. Knee Surg Sports Traumatol Arthrosc (2015) 0.75
Rescued Chondrogenesis of Mesenchymal Stem Cells under Interleukin 1 Challenge by Foamyviral Interleukin 1 Receptor Antagonist Gene Transfer. Front Pharmacol (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta (1986) 13.69
Construction of adenovirus vectors through Cre-lox recombination. J Virol (1997) 6.72
Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem (1988) 4.68
Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature (1986) 4.24
Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum (2006) 4.16
The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am (1998) 3.32
The surface of articular cartilage contains a progenitor cell population. J Cell Sci (2004) 3.28
NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci U S A (1998) 2.61
FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol (2005) 2.31
NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest (1998) 2.27
Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum (2004) 2.23
Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-alpha. J Biol Chem (2000) 1.86
Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther (2007) 1.85
Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes a decreased number of normal proteoglycan molecules. Biochem J (1985) 1.68
Gene transfer to human joints: progress toward a gene therapy of arthritis. Proc Natl Acad Sci U S A (2005) 1.57
Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells. J Immunol (1998) 1.51
BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. J Cell Physiol (2001) 1.40
High-throughput aggregate culture system to assess the chondrogenic potential of mesenchymal stem cells. Biotechniques (2005) 1.35
NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev (2003) 1.33
Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application. Injury (2007) 1.28
Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo. Am J Med (1987) 1.22
Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway. FEBS Lett (2002) 1.21
Enhanced integrative repair of the porcine meniscus in vitro by inhibition of interleukin-1 or tumor necrosis factor alpha. Arthritis Rheum (2007) 1.21
Glucosamine promotes chondrogenic phenotype in both chondrocytes and mesenchymal stem cells and inhibits MMP-13 expression and matrix degradation. Osteoarthritis Cartilage (2007) 1.19
Interleukin-1beta impairment of transforming growth factor beta1 signaling by down-regulation of transforming growth factor beta receptor type II and up-regulation of Smad7 in human articular chondrocytes. Arthritis Rheum (2007) 1.17
Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthritis Cartilage (2007) 1.16
Osteogenic potential of reamer irrigator aspirator (RIA) aspirate collected from patients undergoing hip arthroplasty. J Orthop Res (2009) 1.15
Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro. Mol Ther (2005) 1.15
Dual transduction of insulin-like growth factor-I and interleukin-1 receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model. J Orthop Res (2005) 1.15
Articular cartilage: injury pathways and treatment options. Sports Med Arthrosc (2006) 1.14
Protection of islets by in situ peptide-mediated transduction of the Ikappa B kinase inhibitor Nemo-binding domain peptide. J Biol Chem (2003) 1.12
Interleukin-1beta up-regulation of Smad7 via NF-kappaB activation in human chondrocytes. Arthritis Rheum (2008) 1.04
Autologous conditioned serum in the treatment of orthopedic diseases: the orthokine therapy. BioDrugs (2007) 1.01
Gene transfer to articular chondrocytes with recombinant adenovirus. Methods Mol Biol (2003) 0.99
Engineered mesenchymal stem cells for cartilage repair. Regen Med (2006) 0.99
Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid. J Orthop Res (2004) 0.98
The use of TNF-alpha blocking agents in rheumatoid arthritis: an update. Expert Opin Pharmacother (2007) 0.96
A rapid and ultrasensitive method for measurement of DNA, calcium and protein content, and alkaline phosphatase activity of chondrocyte cultures. Calcif Tissue Int (1995) 0.95
Gene therapy for arthritis: what next? Arthritis Rheum (2006) 0.95
MAP kinases and NF-kappaB collaborate to induce ICAM-1 gene expression in the early phase of adenovirus infection. Virology (2003) 0.93
In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors. Methods Mol Med (2004) 0.91
The efficacy and tolerability of newer biologics in rheumatoid arthritis: best current evidence. Curr Opin Rheumatol (2007) 0.89
Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. Osteoarthritis Cartilage (1997) 0.84
A simple, lanthanide-based method to enhance the transduction efficiency of adenovirus vectors. Gene Ther (2008) 0.83
IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis. Expert Opin Investig Drugs (2000) 0.83
Design and self-assembly of two-dimensional DNA crystals. Nature (1998) 9.59
Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev (1989) 7.47
Glutamate-mediated astrocyte-neuron signalling. Nature (1994) 6.75
Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58. Science (2001) 5.16
Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest (2001) 5.05
Combinatorial roles of the nuclear receptor corepressor in transcription and development. Cell (2000) 3.47
The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev (1997) 3.28
A family of immunologically related transcription factors that includes multiple forms of ATF and AP-1. Genes Dev (1988) 3.13
Vitreous surgery for macular holes. Ophthalmology (1993) 2.91
Nitric oxide and arthritis. Arthritis Rheum (1993) 2.83
New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasound and Doppler. Eur Heart J (1999) 2.67
Osteoblast and chondroblast differentiation. Bone (1995) 2.65
Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature (1999) 2.64
Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Thorac Cardiovasc Surg (1998) 2.49
Imaging through a scattering wall using absorption. Opt Lett (1991) 2.43
Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeys. Neurotoxicol Teratol (2011) 2.41
Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice. Kidney Int (2007) 2.39
Semen quality of fertile US males in relation to their mothers' beef consumption during pregnancy. Hum Reprod (2007) 2.26
Three-dimensional visualization of tegument/capsid interactions in the intact human cytomegalovirus. Virology (1999) 2.20
Regulation of somatic growth by the p160 coactivator p/CIP. Proc Natl Acad Sci U S A (2000) 2.17
Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine (Phila Pa 1976) (1996) 2.13
Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr Med Chem (2000) 2.08
Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol (1991) 2.07
Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res (2010) 2.07
Mechanism of TGFbeta receptor inhibition by FKBP12. EMBO J (1997) 2.06
The TRAPP complex is a nucleotide exchanger for Ypt1 and Ypt31/32. Mol Biol Cell (2000) 2.05
Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology (1999) 2.02
Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J (2001) 1.96
Toward a biochemical understanding of human intervertebral disc degeneration and herniation. Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases. Spine (Phila Pa 1976) (1997) 1.94
Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature (1992) 1.93
Identification of the herpes simplex virus-1 protease cleavage sites by direct sequence analysis of autoproteolytic cleavage products. J Biol Chem (1993) 1.92
Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development. Genes Dev (1999) 1.88
RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int (2006) 1.88
Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci U S A (2001) 1.84
STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity (2001) 1.81
Cell cycle regulation of the p34cdc2 inhibitory kinases. Mol Biol Cell (1994) 1.81
Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol (2001) 1.80
Post-translational modifications of tau protein in Alzheimer's disease. J Neural Transm (Vienna) (2004) 1.78
ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences. J Thromb Haemost (2006) 1.75
Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia. Diabetologia (2006) 1.74
Prenatal phthalate exposure and reduced masculine play in boys. Int J Androl (2009) 1.69
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci U S A (1993) 1.65
Prolonged systemic expression of human IL-1 receptor antagonist (hIL-1ra) in mice reconstituted with hematopoietic cells transduced with a retrovirus carrying the hIL-1ra cDNA. Gene Ther (1995) 1.63
Estimating human age from T-cell DNA rearrangements. Curr Biol (2010) 1.58
Heterogeneous expression of Gap junction channels in the heart leads to conduction defects and ventricular dysfunction. Circulation (2001) 1.58
Antioxidative activity of natural products from plants. Life Sci (2000) 1.56
Emerging issues in public health: a perspective on China's healthcare system. Public Health (2010) 1.55
Neuropathology in older people with disequilibrium of unknown cause. Neurology (1999) 1.54
Incorporation of 5-substituted uracil derivatives into nucleic acids. II. Incorporation of 5-vinyluracil into the DNA of Escherichia coli. Biochim Biophys Acta (1973) 1.54
Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc Natl Acad Sci U S A (1998) 1.54
Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene. Gene Ther (2002) 1.53
Microtubule disassembly increases endothelial cell barrier dysfunction: role of MLC phosphorylation. Am J Physiol Lung Cell Mol Physiol (2001) 1.52
Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor beta 1 encoding gene. Spine (Phila Pa 1976) (1999) 1.51
Subsurface tumor progression investigated by noninvasive optical second harmonic tomography. Proc Natl Acad Sci U S A (1999) 1.51
The natural history of the anterior cruciate ligament-deficient knee. Changes in synovial fluid cytokine and keratan sulfate concentrations. Am J Sports Med (1998) 1.51
Outcomes of maintenance therapy with tacrolimus versus azathioprine for active lupus nephritis: a multicenter randomized clinical trial. Lupus (2012) 1.50
Cyclic tensile strain acts as an antagonist of IL-1 beta actions in chondrocytes. J Immunol (2000) 1.47
Management of pterygium with surgery and radiation therapy. The North Florida Pterygium Study Group. Int J Radiat Oncol Biol Phys (1994) 1.45
Suppression of airway inflammation by a natural acute infection of the intestinal epithelium. Mucosal Immunol (2008) 1.44
Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma. Phys Rev Lett (2010) 1.44
A role for G-CSF receptor signaling in the regulation of hematopoietic cell function but not lineage commitment or differentiation. Immunity (1999) 1.42
Adenoviral transduction of human osteoblastic cell cultures: a new perspective for gene therapy of bone diseases. Acta Orthop Scand (1999) 1.42
Complete sequence analysis of mitochondrial DNA of aplastic anemia patients. Genet Mol Res (2012) 1.41
Second-harmonic tomography of tissues. Opt Lett (1997) 1.41
Effect of transcatheter renal arterial embolization combined with cryoablation on regulatory CD4+CD25+ T lymphocytes in the peripheral blood of patients with advanced renal carcinoma. Cryobiology (2012) 1.39
N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum (1994) 1.39
Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1. Clin Pharmacol Ther (2007) 1.39
High-volume nonionic dimeric contrast medium: first experiences during complex coronary interventions. Cathet Cardiovasc Diagn (1997) 1.39
Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther (2000) 1.39
Observation of an antimatter hypernucleus. Science (2010) 1.38
Gene transfer to synoviocytes: prospects for gene treatment of arthritis. DNA Cell Biol (1992) 1.37
Wnt/beta-catenin signaling: a promising new target for fibrosis diseases. Physiol Res (2012) 1.37
Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin. J Biol Chem (1997) 1.37
Cyclic tensile stress exerts antiinflammatory actions on chondrocytes by inhibiting inducible nitric oxide synthase. J Immunol (1999) 1.36
Neoplastic transformation of guinea pig fetal cells in culture induced by chemical carcinogens. Cancer Res (1975) 1.35
Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol (1996) 1.33
Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol (1997) 1.32
Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer (1993) 1.31
Constitutive intra-articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis. J Immunol (1997) 1.31
Hypertonic saline resuscitation diminishes lung injury by suppressing neutrophil activation after hemorrhagic shock. Shock (1998) 1.31
Reconstitution and transphosphorylation of TGF-beta receptor complexes. EMBO J (1994) 1.30
Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene (2007) 1.30
Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. Clin Pharmacol Ther (2010) 1.30
Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter. Proc Natl Acad Sci U S A (2000) 1.29
Genetic and biochemical analysis of an endonuclease encoded by the IncN plasmid pKM101. Nucleic Acids Res (1993) 1.29
Nitric oxide in osteoarthritis. Osteoarthritis Cartilage (1999) 1.29
Spatial distribution of two-photon-excited fluorescence in scattering media. Appl Opt (1999) 1.27
Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4. J Immunol (2001) 1.27
Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK. J Biol Chem (2000) 1.27
Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest. Cancer Res (2000) 1.26
Kinetics of osteoprogenitor proliferation and osteoblast differentiation in vitro. J Cell Biochem (1999) 1.26
Reduced levels of human apoE4 protein in an animal model of cognitive impairment. Neurobiol Aging (2009) 1.26
Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli. Proc Natl Acad Sci U S A (2000) 1.26
Mycobacterium thermoresistibile infection in an immunocompromised host. J Clin Microbiol (1984) 1.25
Phosphorylation of protein kinase N by phosphoinositide-dependent protein kinase-1 mediates insulin signals to the actin cytoskeleton. Proc Natl Acad Sci U S A (2000) 1.24
Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol (1999) 1.24
Polyethylene glycol-grafted poly-L-lysine as polymeric gene carrier. J Control Release (1998) 1.24
Gene delivery to cartilage defects using coagulated bone marrow aspirate. Gene Ther (2004) 1.24